Immunogenicity of malaria transmission-blocking vaccine candidate, y230.CA14 following crosslinking in the presence of tetanus toxoid. | Parasite Immunol;21(11): 573-81, 1999 Nov. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Immunogenicity of malaria transmission-blocking vaccine candidate, y230.CA14 following crosslinking in the presence of tetanus toxoid.

Vincent, A A; Fanning, S; Caira, F C; Williamson, K C.

Affiliation

Vincent AA; Department of Biology, Loyola University Chicago, 6525 North Sheridan Road, Chicago, IL 60626, USA.

Parasite Immunol ; 21(11): 573-81, 1999 Nov.

Article in En | MEDLINE | ID: mdl-10583858

Subject(s)

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Plasmodium falciparum / Tetanus Toxoid / Protozoan Proteins / Malaria Vaccines / Antigens, Protozoan Limits: Animals Language: En Journal: Parasite Immunol Year: 1999 Document type: Article Affiliation country:

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Plasmodium falciparum / Tetanus Toxoid / Protozoan Proteins / Malaria Vaccines / Antigens, Protozoan Limits: Animals Language: En Journal: Parasite Immunol Year: 1999 Document type: Article Affiliation country: